Not Tagged
sanofi
['regeneron']
despite increasing advancements in #multiplemyeloma research, available therapeutic options can lead to high healthcare costs and poor outcomes for patients. we re presenting data on real-world outcomes in rrmm at #asco22. learn more: 
Official channel for Regeneron. We turn science into medicine for people with serious diseases. View our terms of engagement here https://t.co/of3QRL6CsA